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Abstract
Background: Treatment guidelines for asthma have been established based on asthma severity; there are limitations
in the identification of underlying pathophysiology and prediction of prognosis in heterogeneous phenotypes of
asthma. Although the complex interactions between environmental and genetic factors affect the development and
progression of asthma, studies on asthma phenotypes considering environmental factors are limited. This study aimed
to identify asthma phenotypes using latent class analysis including environmental factors in school-age children.
Methods: We included 235 children (6–8 years) with parent-reported, physician-diagnosed asthma from the Children’s
HEalth and Environmental Research (CHEER) study, which is a 4-year prospective follow-up study with 2-year intervals. At
every survey, pulmonary function tests, methacholine challenge tests and blood tests with questionnaire were conducted.
Results: Four asthma phenotypes were identified. Cluster 1 (22% of children) was characterized by high
prevalence of atopy and mild symptoms; subjects in cluster 2 (17%) consisted of less atopy and normal lung function,
but intermittent troublesome; cluster 3 (29%) experienced late-onset atopic troublesome asthma with decreased lung
function in combination with low socioeconomic status; and cluster 4 was associated with early-onset and less-atopic
infrequent asthma.
Conclusions: Late-onset, high atopy, and low socioeconomic status are associated with troublesome persistent
asthma phenotype in school-age children. Environmental factors might be implicated in the clinical heterogeneity of
asthma. Asthma phenotypes considering diverse factors might be more helpful in the identification of asthma
pathogenesis and its prevention.
Keywords: Asthma, Atopy, Children, Phenotype, Socioeconomic status
Background
Asthma is characterized by airway hyperresponsiveness
and reversible airway obstruction, which results from
complex interactions between genetic and environmen-
tal factors [1]. Wheezing in early life is usually associated
with viral respiratory tract infection; however, frequent
recurrence in these groups causes a considerable health-
care burden [2]. Owing to the clinical and pathophysio-
logical heterogeneity of asthma, there have been diverse
attempts to phenotype asthma [3–7]. However, the
actual clinical application of phenotyping asthma was
based on symptom severity [8]. Classification of asthma
is important to predict the prognosis and response to
treatment and understand its underlying mechanisms;
however, studies on asthma phenotypes using compre-
hensive factors are limited.
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Epidemiologic studies have considered instability of
asthma phenotypes over time [3, 4, 7] and identified
associated risk factors for each asthma phenotype [9]. How-
ever, such studies considering environmental factors for the
classification of asthma phenotypes are limited, although
environmental factors play an important role as causative
and provocative factors for asthma [10]. Additionally, few
studies artificially classified asthma phenotypes according
to onset age and/or persistence of wheezing, despite diverse
factors affecting the development and progression of
asthma [9, 11]. Environmental factors affect the develop-
ment of airway during antenatal and/or postnatal period
through epigenetic or non-epigenetic mechanisms [12, 13].
Although persistent troublesome wheeze is known to be as-
sociated with atopy, bronchial hyperresonsiveness (BHR),
and decreased pulmonary function compared with con-
trolled asthma [6, 14], these studies described pheno-
types of preschool wheezing based on temporal
patterns of symptoms combined with symptom
control. Another study showed that sex is a risk
factor for different asthma phenotypes [15]. However,
these studies have limitations in identification of the
underlying pathology according to phenotypes. No
study has shown how environmental factors combined
with genetic factors reflected in parental history of
allergic diseases and demographic factors are associ-
ated with the heterogeneity of asthma, which would
be helpful to investigate the origin of asthma.
The aim of this study was to identify asthma phenotypes
based on environmental factors and clinical characteristics
of asthma in school-age children using latent class analysis
(LCA), which is an unsupervised statistical method for
classification [16]. Additionally, we investigated the
prognosis of each asthma phenotype and changes in
biomarkers during the prospective follow-ups.
Methods
Study population
This study was a part of Children’s HEalth and Environ-
mental Research (CHEER) study, which aimed to evalu-
ate the effect of environmental factors on children’s
health [16–18]. The study population was enrolled from
January 2005 to December 2006, and they were
followed-up for 4 years with 2-year intervals until
December 2010 in randomly selected nationwide elem-
entary schools in Korea [16, 17]. This cohort study
consisted of parent-completed questionnaire, skin prick
tests (SPTs), blood tests for total serum IgE levels and
eosinophil percentages, pulmonary function tests, and
methacholine challenge tests at every survey. The
Korean version of the International Study of Asthma
and Allergies in Childhood (ISAAC) questionnaire was
used to assess the presence of allergic diseases [19–21].
Out of the total 2491 children at the time of enrollment in
CHEER study, those (mean age ± standard deviation, 7.5
± 0.9 years) with parent-reported, physician-diagnosed
asthma in lifetime were included in the present study. The
study protocols were reviewed and approved by the
institutional review board (IRB) of Ulsan University
College of Medicine (IRB no. 2006–0081). Written
informed consent was obtained from the parents or
guardians of the study participants Parents or guardians
completed the questionnaire.
Skin prick tests (SPTs)
The SPTs were performed for 13 common inhalant aller-
gens and 4 food allergens [17]. Atopy was defined as at
least one positive SPT response.
Measurement of total serum IgE levels and blood
eosinophil percentages
Total serum IgE levels were measured by using fluores-
cent enzyme immunoassay (AutoCAP system, Phadia
AB, Uppsala, Sweden). The lower limit of total serum
IgE detection was 2 kUA/L. Blood eosinophil percent-
ages were evaluated using NE-8000 system (Sysmex,
Kobe, Japan) from peripheral blood samples.
Lung function test and BHR
Spirometry was performed according to the American
Thoracic Society (ATS)/European Respiratory Society
(ERS) guidelines by using a portable microspirometer
(Microspiro HI-298, Chest Corporation, Tokyo, Japan)
[17, 22, 23]. Details of BHR measurement are provided
in elsewhere [24]. Subjects were considered to have BHR
to methacholine when their methacholine PC20 was
<8 mg/mL. The new development of BHR was defined
as conversion from a negative BHR at enrollment to a
positive BHR at the 4-year follow-up survey.
Cluster analysis
Asthma phenotypes were identified by using LCA. LCA
has been employed previously to identify phenotypes of
asthma, atopic dermatitis (AD), and allergic rhinitis (AR)
[16, 25, 26] because this statistical method can classify
distinctly based on the observed heterogeneity in total
population without bias. Several variables were used to
define asthma phenotypes: demographic characteristics,
namely, sex, body mass index (BMI), and socioeconomic
status (SES) using monthly house hold income (http://
stats.oecd.org) and maternal education level; and envir-
onmental factors, namely, prior exposure to environ-
mental tobacco smoke (ETS), parental history of allergic
diseases (AD, AR, and/or asthma), onset age of the first
wheezing, number of absence days from school and noc-
turnal awakening days owing to asthma attacks, number
of asthma attacks in the previous 12 months, number of
days with treatment for asthma in the previous 12 months
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at the time of enrollment, and SPT, blood tests, and lung
function tests at the time of enrollment. The FEV1 % pre-
dicted and FEV1/FVC were dichotomized as ≥80% and
<80% and for FEF25–75% % predicted as ≥65% and <65%.
Based on the Bayesian information criteria, a model with
four latent classes was selected as the best model for
CHEER data [27].
Statistical analysis
To evaluate the differences in characteristics and pa-
rameters among the four asthma phenotypes, we used
the t test for independent comparisons between two
groups, Fisher exact test for categorical variables, or
Kruskal–Wallis test for continuous variables. Multiple
testing was conducted using the Bonferroni correction
when needed. P < 0.05 was considered significant. All
statistical analyses were performed using SAS for
Windows (version 9.2).
Results
Characteristics of study population
The characteristics of the study population are shown in
Table 1. Mean age of the enrolled children was 7.5 years,
and 63.4% of the study population were boys. The preva-
lence of parental history of allergic diseases, atopy, and
physician-diagnosed AR and AD in lifetime was signifi-
cantly higher in the included subjects compared to those
excluded due to the absence of physician-diagnosed
asthma history.
Cluster 1 (atopic mild asthma)
Fifty-one children (21.7%) were grouped into cluster 1,
which was characterized by atopic mild asthma (Table 2).
Atopy was observed in 46 children (90.2% of the
children in this cluster). Onset age of the first wheezing
in this cluster ranged widely from ≤ 1 year to > 6 years of
age. None of the children in this cluster complained of
absence days from school and nocturnal awakening days
due to asthma attacks in the previous 12 months at the
time of enrollment. Forty-two children (82.4%) had no
asthma attacks in the previous 12 months at the time of
enrollment. However, BHR was observed for 44.9% of
the children (n = 22/49) and > 100 IU/mL of total serum
IgE levels for 98.0% (n = 50/51).
Cluster 2 (less atopic, troublesome asthma)
Forty children (17.0% of the enrolled children) were
assigned to cluster 2, characterized by normal lung func-
tion with moderately troublesome asthma with high
SES, reflected by monthly household income and mater-
nal educational levels. Obesity was observed in 17.9% of
the children (n = 7/39) in this cluster. This cluster had
the lowest prevalence of low monthly income (n = 21/40,
52.5%) and lower levels of maternal educational levels
Table 1 Characteristics of study population
Variables Participants in 4 clusters Excluded in LCA P value
Number 235/2491 (9.4%) 2256/2491 (90.6%)
Male 149/235 (63.4%) 1148/2256 (50.9%) <0.001
Age (years), mean ± SD 7.5 ± 0.9 7.7 ± 1.1 <0.001
BMI (kg/m2), mean ± SD 16.95 ± 2.4 16.87 ± 2.6 0.677
Parental allergic diseases, yes 97/227 (42.7%) 582/2114 (27.5%) <0.001
Maternal educational levels, ≤ High school 133/222 (59.9%) 1261/1967 (64.1%) 0.218
Parental monthly income, < 3000 USD 152/230 (66.1%) 1501/2132 (70.4%) 0.175
ETS exposure, yes 106/227 (46.7%) 910/2004 (45.4%) 0.712
Atopy on skin prick tests 104/234 (44.4%) 583/2254 (25.9%) <0.001
Total serum IgE (IU/ml), mean [range] 454 [3.80–4630] 250.80 [1.40–6934] <0.001
Blood eosinophils (%), mean [range] 4.67 [0.50–39.10] 3.57 [0–22.60] <0.001
AR diagnosis, ever 107/234 (45.7%) 462/2081 (22.2%) <0.001
AD diagnosis, ever 99/233 (42.5%) 642/2075 (30.9%) <0.001
FEV1 % predicted 102.4 ± 13.77 106.1 ± 12.96 <0.001
FEV1/FVC 88.86 ± 6.06 90.86 ± 5.54 <0.001
FEF25–75% % predicted 91.92 ± 21.88 99.91 ± 22.64 <0.001
BHR (PC20 < 8 mg/ml) 80/221 (36.2%) 408/2204 (18.5%) <0.001
Data are presented as number (%) or mean ± standard deviation
Definition of abbreviations: AD atopic dermatitis, AR allergic rhinitis, BHR methacholine PC20 < 8mg/ml, BMI, body mass index, ETS environmental tobacco smoke,
FEF25–75% Forced expiratory flow at 25–75% of forced vital capacity, FEV1 Forced expiratory volume in 1 s, FVC Forced vital capacity, LCA latent class analsis, SD
standard deviation, USD US dollars
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(n = 15/36, 41.7%). All the children in this cluster experi-
enced wheezing more than once in the previous 12
months at the time of enrollment. Sixteen children
(40%) of this cluster experienced absence days from
school due to asthma attacks in the previous 12 months,
and 27 children (67.5%) experienced nocturnal
Table 2 Results of latent class analysis
Cluster Cluster 1 Cluster 2 Cluster 3 Cluster 4
Number, n (%) 51 (21.7%) 40 (17.0%) 29 (12.3%) 115 (49.1%)
Sex, Male 28/51 (54.9%) 30/40 (75.0%) 14/29 (48.3%) 77/115 (67.0%)
Body mass index
Normal 43/51 (84.3%) 31/39 (79.5%) 29/29 (100.0%) 88/111 (79.3%)
Overweight 8/51 (15.7%) 1/39 (2.6%) 0/29 (0.0%) 16/111 (14.4%)
Obesity 0/51 (0.0%) 7/39 (17.9%) 0/29 (0.0%) 7/111 (6.3%)
Family history of allergic diseases, yes 28/50 (56.0%) 14/38 (36.8%) 16/26 (61.5%) 39/113 (34.5%)
Monthly income, < 3000 USD 32/49 (65.3%) 21/40 (52.5%) 26/28 (92.9%) 73/113 (64.6%)
Maternal educational level
Less than high school 30/46 (65.2%) 15/36 (41.7%) 21/29 (72.4%) 67/111 (60.4%)
Exposure to ETS, yes 12/50 (24.0%) 20/38 (52.6%) 17/28 (60.7%) 57/111 (51.4%)
Atopy, yes 46/51 (90.2%) 18/40 (45.0%) 27/29 (93.1%) 13/114 (11.4%)
Onset age of first wheezing
< 1 year 10/44 (22.7%) 5/35 (14.3%) 0/28 (0.0%) 18/103 (17.5%)
1–3 years 9/44 (20.5%) 9/35 (25.7%) 6/28 (21.4%) 46/103 (44.7%)
3–6 years 11/44 (25.0%) 14/35 (40.0%) 17/28 (60.7%) 29/103 (28.2%)
≥ 6 years 14/44 (31.8%) 7/35 (20.0%) 5/28 (17.9%) 10/103 (9.7%)
Number of absence days from school due
to wheezinga
0 51/51 (100.0%) 24/40 (60.0%) 18/29 (62.1%) 115/115 (100.0%)
1–3 days 0/51 (0.0%) 15/40 (37.5%) 5/29 (17.2%) 0/115 (0.0%)
4–6 days 0/51 (0.0%) 0/40 (0.0%) 4/29 (13.8%) 0/115 (0.0%)
≥ 7 days 0/51 (0.0%) 1/40 (2.5%) 2/29 (6.9%) 0/115 (0.0%)
Number of nocturnal awakening days due
to wheezinga
0 51/51 (100.0%) 13/40 (32.5%) 9/29 (31.0%) 115/115 (100.0%)
< 1 /week 0/51 (0.0%) 24/40 (60.0%) 15/29 (51.7%) 0/115 (0.0%)
≥ 1 /week 0/51 (0.0%) 3/40 (7.5%) 5/29 (17.2%) 0/115 (0.0%)
Number of asthma attacka
0 42/51 (82.4%) 0/40 (0.0%) 0/29 (0.0%) 108/115 (93.9%)
1–3 9/51 (17.6%) 26/40 (65.0%) 11/29 (37.9%) 7/115 (6.1%)
4–12 0/51 (0.0%) 8/40 (20.0%) 7/29 (24.1%) 0/115 (0.0%)
≥ 13 0/51 (0.0%) 6/40 (15.0%) 11/29 (37.9%) 0/115 (0.0%)
Asthma treatmenta, yes 19/51 (37.3%) 32/40 (80.0%) 27/29 (93.1%) 21/115 (18.3%)
Total serum IgE ≥100 IU/mL 50/51 (98.0%) 24/40 (60.0%) 28/28 (100.0%) 30/111 (27.0%)
Blood eosinophil ≥4% 28/51 (54.9%) 24/40 (60.0%) 23/29 (79.3%) 29/112 (25.9%)
BHR <8 mg/ml 22/49 (44.9%) 12/38 (31.6%) 21/26 (80.8%) 25/108 (23.1%)
FEV1 < 80% predicted 7/47 (14.9%) 0/39 (0.0%) 4/29 (13.8%) 1/113 (0.9%)
FEV1/FVC <80% predicted 1/49 (2.0%) 0/40 (0.0%) 11/29 (37.9%) 8/114 (7.0%)
FEF25–75% <65% predicted 5/29 (17.2%) 0/30 (0.0%) 8/19 (42.1%) 4/90 (4.4%)
ain the previous 12 months
Definition of abbreviations: BHR methacholine PC20 < 8mg/ml, ETS environmental tobacco smoke, FEF25–75% Forced expiratory flow at 25–75% of forced vital
capacity, FEV1 Forced expiratory volume in 1 s, FVC Forced vital capacity, USD US dollars
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awakening days due to asthma attacks in the previous 12
months at the time of enrollment. However, all the
children had normal lung function. Out of 38, 12
children (31.6%) in this cluster showed positive BHR.
Cluster 3 (atopic, persistently troublesome asthma)
Twenty–nine children (12.3%) were grouped in this clus-
ter. Children in this cluster experienced their first
wheezing after 1 year of age. All children had normal
BMI. Further, the highest prevalence of low SES was ob-
served. The quality of life due to asthma attacks was
poorest in this cluster; all the children experienced
wheezing in the previous 12 months, and 27 children
(93.1%) were treated for asthma attacks in the previous
12 months at the time of enrollment; 11 children
(37.9%) were reported to have absence days from school
due to asthma attacks and 20 children (69.0%) experi-
enced nocturnal awakening owing to asthma attacks in
the previous 12 months at the time of enrollment. The
total serum IgE levels were >100 IU/mL for all the chil-
dren, and blood eosinophil percentage was >4% in 23
children (79.3%). Out of 26 children, 21 (80.8%) showed
positive BHR, and four of the total children showed
<80% of FEV1 % predicted.
Cluster 4 (less-atopic mild asthma)
One hundred fifteen children (48.9%) were included in
this cluster, which was the largest. The prevalence of atopy
and parental history of allergic diseases including AD, AR,
and asthma was the lowest (n = 39/113, 34.5%; n = 13/114,
11.4%, respectively). Seven children (6.1%) experienced
asthma attacks, although 21 children (18.3%) were treated
due to asthma exacerbation during the previous 12
months at the time of enrollment. However, none of the
children in this cluster were reported to have any absence
days from school or nocturnal awakening days due to
asthma attacks in the previous 12 months at the time of
enrollment. The prevalence of ≥100 IU/ml of total serum
IgE levels (n = 30/111; 27.0%) and ≥4% of blood eosinophil
percentages (n = 29/112; 25.9%) was the lowest in this
cluster. Additionally, the prevalence of BHR was the low-
est (n = 25/108; 23.1%), and most of the children in this
cluster showed normal lung function.
Comorbidities
The prevalence of parent-reported, physician-diagnosed
AR in lifetime was the highest in cluster 4 (60.0%),
followed by clusters 2 (57.5%) and 1 (56.0%) (Table 3).
The prevalence of parent-reported, physician-diagnosed
AD in lifetime was the highest in cluster 3 (55.2%),
followed by clusters 2 (50.0%) and 4 (39.5%). The preva-
lence of parent-reported, physician-diagnosed food al-
lergy in lifetime was the highest in cluster 2 (15.4%),
followed by cluster 4 (12.4%), although no significant
differences were observed among the clusters.
Biomarkers
Mean values of the total serum IgE and blood eosinophil
percentages showed a decreasing pattern as the children
grew in each cluster (Table 4). The total serum IgE levels
and blood eosinophil percentages were the highest in
cluster 3, followed by clusters 2, 4, and 1. This decreas-
ing pattern was observed even at the final survey.
The prevalence of sensitization to indoor allergens was
the highest in cluster 3 (n = 25/29; 86.2%), followed by
clusters 1 (n = 42/51; 82.4%), 2 (n = 17/40; 42.5%), and 4
(n = 11/114; 9.7%) at the time of enrollment (Fig. 1). The
statistical differences in the prevalence of sensitization
were observed between clusters 2 and 3 and between
clusters 1 and 4. The same pattern was observed at the
final survey with no statistical differences between clus-
ters 2 and 3. Cluster 3 showed the highest prevalence of
sensitization to outdoor allergens (n = 8/29; 27.6%) at
the time of enrollment without statistical differences.
Lung function
At the time of enrollment, mean values of FEV1 %
predicted in cluster 3 (mean, 94.4; 95% confidence inter-
vals [CI], 87.9–101.0) were significantly lower than that
in cluster 1 (mean, 98.3; 95% CI, 94.0–102.5), compared
with clusters 2 (mean, 107.0; 95% CI, 103.0–111.1) and 4
(mean, 104.6; 95% CI, 102.4–106.8) (Fig. 2). This pattern
in FEV1 % predicted was also observed at the final sur-
vey. Mean levels of FEV1/FVC % predicted in cluster 3
(mean, 83.3; 95% CI, 80.7–85.9) were significantly lower
compared with those in cluster 2 (mean, 89.9; 95% CI,
88.4–91.5) at the time of enrollment. However, no sig-
nificant differences in FEV1/FVC % predicted between
clusters 2 (mean, 88.9; 95% CI, 85.9–92.0) and 3 (mean,
84.4; 95% CI, 77.4–91.3) were observed, although FEV1/
FVC % predicted was the lowest in cluster 3 at the final
survey.
The levels of FEF25–75% % predicted were lowest in
cluster 3. The levels of FEF25–75% % predicted were
Table 3 Comorbidities of allergic diseases at the time of enrollment according to asthma clusters
Cluster 1 Cluster 2 Cluster 3 Cluster 4 P value
Allergic rhinitis 28/50 (56.0) 23/40 (57.5) 00/29 (34.5) 46/115 (60.0) 0.061
Atopic dermatitis 18/50 (36.0) 20/40 (50.0) 16/29 (55.2) 45/114 (39.5) <0.001
Food allergy 2/49 (4.1) 6/39 (15.4) 2/28 (7.1) 14/113 (12.4) 0.269
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significantly lower in cluster 3 compared with those
in cluster 2 both at the time of enrollment and at the
final survey. However, no significant differences in the
levels of FEF25–75% % predicted were observed
between clusters 1 and 4 both at the time of enroll-
ment and at the final survey.
Prognosis
The prevalence of new-onset BHR during the prospect-
ive follow-ups was the highest in cluster 3 (n = 3/5;
60.0%), followed by clusters 1 (n = 8/21; 38.1%) and 4 (n
= 5/64; 7.8%) (Table 5). The persistence rate of BHR was
the highest in cluster 1 (n = 12/20; 60.0%), followed by
Table 4 Total serum IgE levels and blood eosinophil percentages at the time of enrollment and follow-up
Variables At the time of enrollment Follow-up
Cluster 1 Cluster 2 Cluster 3 Cluster 4 P value Cluster 1 Cluster 2 Cluster 3 Cluster 4 P value
Total serum IgE
levels (IU/mL)
mean (N) 746.8 (51) 306.1 (40) 1238.0 (28) 175.0 (111) <0.001 378.9 (35) 148.7 (22) 447.7 (17) 77.2 (68) <0.001
95% CI 519.3–974.3 125.4–486.9 738.0–1738.0 87.7–262.6 296.8–460.9 86.0–211.4 268.3–627.1 45.0–109.5
Blood
eosinophil, %
mean (N) 5.7 (51) 5.3 (40) 6.2 (29) 3.6 (112) <0.001 4.4 (35) 3.8 (22) 5.4 (17) 3.1 (69) 0.002
95% CI 4.6–6.8 4.1–6.5 4.9–7.6 2.8–4.3 3.5–5.3 2.5–5.1 3.8–7.0 2.7–3.6
Definition of abbreviations: CI confidence intervals, N number
Fig. 1 Sensitization according to asthma phenotypes. a Sensitizations to indoor allergens both at the time of enrollment and follow-up. b Sensitizations to
outdoor allergens both at the time of enrollment and follow-up. $P value < 0.005, compared with cluster 1. #P value < 0.005, compared with cluster 2. &P
value < 0.005, compared with cluster 3
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cluster 3 (n = 7/15; 46.7%). The remission rate of BHR
was the highest in cluster 4 (n = 20/22; 90.9%), followed
by cluster 2 (n = 6/7; 85.7%). The prevalence of asthma
attacks during the previous 12 months at follow-ups was
the highest in cluster 3 (n = 13/24; 54.2%), followed by
cluster 2 (n = 10/26; 38.5%).
Discussion
In the present prospective general-population based
study, we identified four distinct asthma clusters in
school-age children (Additional file 1: Figure S1). More
frequent asthma attacks in the previous 12 months at
the time of enrollment were observed in two asthma
Fig. 2 Changes in pulmonary function according to asthma clusters. a FEV1 % predicted at the time of enrollment. b FEV1 % predicted at the
time of follow-up. c FEV1/FVC % predicted at the time of enrollment. d FEV1/FVC % predicted at the time of follow-ups. e FEF25–75% % predicted
at the time of enrollment. f FEF25–75% % predicted at the time of follow-ups.
*P value < 0.05
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phenotypes (clusters 2 and 3) among the four clusters.
However, the two clusters differed in SES; cluster 3
included children with lower SES, whereas prevalence of
high SES was higher in cluster 2. Additionally, cluster 3
had a higher prevalence of atopy combined with an
increased prevalence of BHR and decreased lung func-
tion. The other two clusters (clusters 1 and 4) included
less frequent asthma attacks; however, they differed in
atopy prevalence. The higher prevalence of atopy and
≥100 IU/mL of total serum IgE was observed in cluster
1. However, 17.6% of the children in cluster 1 had expe-
rienced asthma attacks in the previous 12 months at the
time of enrollment; positive BHR was observed in about
45%. These findings suggest that asthma phenotypes in
children can be determined based on atopy and SES
combined with symptom severity. The comprehensive
consideration of diverse factors might contribute to the
identification of the origin of asthma. To our knowledge,
this study is the first to identify asthma phenotypes
using severity, atopy burden, and SES in school-age
children.
Guidelines for asthma treatment were suggested
based on asthma severity [8]. However, this classifica-
tion lacks in the reflection of heterogeneity in asthma
phenotypes, especially in children with unpredictable
prognosis as they grew. To identify the phenotypic
heterogeneity over time in children with asthma,
strenuous efforts have been made via the epidemio-
logic studies [6, 9, 23, 28, 29]. The previous studies
classified wheezing phenotype according to onset age
of wheezing and/or persistence of asthma symptoms,
especially in preschool children [29, 30]. Another
study has identified wheezing phenotypes based on
symptom patterns such as episodic viral or multiple-
trigger wheeze in preschool children [31]. Although
these phenotypes have contributed to the prediction of
prognosis in preschool children with wheezing, the
previous studies could not identify the underlying
complex pathologies in each phenotype; because asso-
ciated factors were partially considered for the hetero-
geneity of asthma.
We included BMI, parental history of allergic diseases,
lung function, atopy, asthma symptoms, and SES for
LCA to better understand the complex interactions
between environmental and genetic factors according to
asthma phenotypes and to identify the underlying mech-
anism. SES, one of the differentiating points in two
troublesome asthma phenotypes in the present study,
has been identified to have an inverse association with
asthma regardless of age [32]. In another study, low-
income levels were associated with the development and
persistency of asthma [33–35]. Although the mecha-
nisms underlying the association between SES and
asthma have not been clearly identified, this factor might
affect the pathology of asthma via complex interactions
with other factors in some phenotypes of asthma, as
identified in this study. This might be partially explained
by inconsistent associations determined between SES
and asthma [36]. The association between SES and
asthma can be partially explained by exposure degree to
allergens, gene by environmental interactions, nutrition,
and psychosocial factors [37–39]. These factors are
considered to affect the immune development through
balance between Th1 and Th2 immune response [40,
41], which might be linked to alteration in microbiota in
humans [42–44]. Alterations of colonization in gut or
airway might affect the development and regulation of
immune system with shaping of airway structures and
gene expression through gene-environment interactions;
therefore, they might contribute to the development and
severity of asthma [45–48]. Also, low SES might affect
the control of asthma in the aspect of adherence or
compliance to asthma treatment. However, higher levels
of total serum IgE as well as eosinophil (%) both at the
time of enrollment and follow-up might imply the differ-
ent pathophysiologies underlying more severe asthma, as
shown in cluster 3.
The previous studies have identified that atopy, late-
onset wheeze, and/or BHR are associated with persistent
or severe asthma in children [6, 11, 30]. However, in
another study, multiple trigger wheezing is associated
with decreased pulmonary function regardless atopy or
Table 5 Prognosis of asthma phenotypes according to asthma clusters
Variables Cluster 1 Cluster 2 Cluster 3 Cluster 4 P value
New-onset BHR, n (%) 8/21 (38.1) 1/17 (5.9) 3/5 (60.0) 5/64 (7.8)* <0.001
Persistence of BHR, n (%) 12/20 (60.0) 1/7 (14.3) 7/15 (46.7) 2/22 (9.1)* <0.002
Remission of BHR, n (%) 8/20 (40.0) 6/7 (85.7) 8/15 (53.3) 20/22 (90.9)* 0.002
Wheezing in the previous
12 months at follow-up, n (%)
4/23 (17.4) 10/26 (38.5) 13/24 (54.2) 3/25 (12.0)† 0.005
New-onset AR, n (%) 9/18 (50.0) 6/9 (66.7) 7/15 (46.7) 15/60 (25.0) 0.026
New sensitization on SPT 13/42 (31.0) 4/26 (15.4) 6/23 (26.1) 27/91 (29.7) 0.493
Definition of abbreviations: AR allergic rhinitis, BHR methacholine PC20 < 8 mg/ml, SPT skin prick test
*P value < 0.005, compared with cluster 1
†P value < 0.005, compared with cluster 3
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current wheezing [5]. These contrasting findings suggest
that atopy alone might not explain the severity and
heterogeneity in asthma; however, it can differently
affect the prognosis of asthma depending on phenotypes.
In the present study, cluster 1 was characterized by high
prevalence of atopy similar to cluster 3, in which atopy
was highly prevalent with troublesome and persistent
asthma; however, children in cluster 1 had mild symp-
toms of asthma. Based on the previous and present stud-
ies [5, 14], certain phenotypes of asthma are influenced
by complex combinations that affect interactions
between innate and adaptive immunity [49, 50]; there-
fore, this might contribute to the understanding of the
mechanisms and the development of individualized
treatment according to asthma phenotypes.
The total serum IgE levels and blood eosinophil percent-
ages had similar patterns with degrees of atopy and BHR,
rather than asthma severity, similar to the previous study
[51]. The assessments of these biomarkers help to identify
asthma phenotypes with partial explanation for the under-
lying pathology in these phenotypes. However, high atopy is
not equal to persistence or severity of asthma, as reflected in
cluster 1 in the present and previous studies [4, 5]; it would
be more helpful to consider the more complex factors in the
prediction of prognosis in each phenotype of asthma.
In contrast to the previous studies on wheezing pheno-
types in preschool children [3, 6, 11, 14], a wide overlap in
onset-age of the first wheezing was observed across four
asthma phenotypes in the present study. Overlapping
features are commonly encountered in the results of LCA
and this might practically reflect the real phenomenon in
the classification of asthma. In the previous studies,
late-onset asthma was classified as an independent pheno-
type regardless of persistency of asthma [6, 14]. This
might suggest that onset-age of the first wheezing does
not contribute to the differences in underlying mecha-
nisms according to asthma phenotypes.
Discrepancy in frequency of asthma symptoms and
treatment in the previous 12 months at the time of
enrollment across asthma phenotypes might be attribut-
able to the early application of asthma treatment in the
presence of asthma like symptoms such as cough. The
prevalence of this discrepancy was highest in cluster 4,
which was characterized by less atopic mild asthma
phenotype. This classification might help to predict the
treatment behavior of asthma in each phenotype, and
thereby, facilitate the targeted therapy and patient
education based on asthma phenotypes. This might be
useful to reduce the socioeconomic burden owing to
patient morbidity and mortality in asthma [52].
There are some limitations in this study. Retrospective
recall of childhood events has limitations in accurate
assessment; however, this study included a prospective
follow-up with 2-year intervals for 4 years in school-age
children selected from a nationwide general population.
Physician-diagnosed asthma was also based on parent
reports. However, the prevalence of asthma diagnosis in
the present study was 9.4% (n = 235/2491), which is
compatible with the worldwide prevalence of asthma
(6–9%) [53]. Follow-ups were relatively short. The
assessment on treatment pattern and responses to treat-
ment was lacking. However, disease burden was assessed
using questions on the frequency of nocturnal awaken-
ing days and absence days from school owing to asthma
attacks; this information can indirectly reflect the
diseases course. Moreover, we enrolled nationwide school-
age children with asthma; therefore, the results of this
study can be generalized. Although this study included
several environmental factors for cluster analysis, further
asthma phenotypes including index representatives of air
pollution are needed.
Conclusion
We identified four asthma phenotypes in school-age
children based on severity of asthma, SES, and atopy.
Persistently troublesome asthma was divided into two
phenotypes based on SES with atopy. Mild, intermittent
asthma was divided into two phenotypes according to
the degree of atopy. These findings suggest the import-
ance of factors that affect SES in the classification of
asthma phenotypes to identify the mechanisms underlying
the heterogeneous asthma phenotypes. Consideration of
diverse factors including environmental factors might be
more helpful to identify the underlying pathogenesis ac-
cording to asthma phenotype, prevent progression of
asthma, and elucidate targeted therapy.
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